N@N

Market Maker Surveillance Report. KFS, IDIX, CYH, IBCA, NNVC, IDI, Winning Stocks With Lowest Price Friction For Tuesday, Apri

April 12, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 2385 companies with "abnormal" market making, 1462 companies with positive Friction Factors and 4143 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. KINGSWAY FINANCIAL SERVICES (NYSE:KFS), IDENIX PHARMACEUTICALS INC (NASDAQ:IDIX), COMMUNITY HEALTH SYSTEMS INC (NYSE:CYH), INTERVEST BANCSHARES CORP-A (NASDAQ:IBCA), NANOVIRICIDES INC (OTCBB:NNVC), SEARCHMEDIA HOLDINGS LTD (AMEX:IDI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     KFS        $0.140       13.33%       111,725         53.07%       95,072          45.16%       16,653          1,190   
     IDIX       $0.620       19.44%       1,258,992       58.35%       898,648         41.65%       360,344         5,812   
     CYH        $5.660       21.86%       18,324,729      54.71%       15,017,402      44.83%       3,307,327       5,843   
     IBCA       $0.380       15.70%       460,204         63.88%       256,468         35.60%       203,736         5,361   
     NNVC       $0.200       14.81%       324,834         47.64%       312,881         45.88%       11,953          598     
     IDI        $0.450       21.23%       124,859         54.27%       104,009         45.21%       20,850          463     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows KFS with a dollar gain Tuesday of $0.14000 and a Friction Factor of 1,190 shares. That means that it only took 1,190 more shares of buying than selling to move KFS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

KINGSWAY FINANCIAL SERVICES (NYSE:KFS) - Kingsway Financial Services Inc. provides insurance solutions to individuals and businesses in the United States. The company primarily offers non-standard automobile insurance that covers drivers who do not qualify for standard automobile insurance coverage because of their payment history, driving record, place of residence, age, vehicle type, or other factors, as well as provides commercial automobile insurance products. It distributes its products through a network of independent agents. The company was founded in 1989 and is based in Mississauga, Canada.

IDENIX PHARMACEUTICALS INC (NASDAQ:IDIX) - Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases in the United States and Europe. The company primarily focuses its research and development on the treatment for hepatitis C virus. The company develops nucleoside/nucleotide polymerase inhibitors, including IDX184, a liver-targeted nucleotide prodrug candidate, which is in phase IIa clinical trial; and IDX102 that completed late-stage preclinical development. It also develops IDX375, a novel palm-binding polymerase inhibitor that is in phase I program; IDX320, a protease inhibitor candidate, which is in phase I healthy volunteer clinical study; and NS5A inhibitors. In addition, the company licensed its telbivudine (Tyzeka/Sebivo), a drug for the treatment of hepatitis B virus, to Novartis Pharma AG; and GSK2248761, a drug candidate from the class of compounds known as non-nucleoside reverse transcriptase inhibitors (NNRTIs), for the treatment of human immunodeficiency virus type 1 and acquired immune deficiency syndrome to GlaxoSmithKline. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

COMMUNITY HEALTH SYSTEMS INC (NYSE:CYH) - Community Health Systems, Inc. provides healthcare services through the operation of hospitals in the United States. The company offers a range of general and specialized hospital healthcare services, including general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics, and diagnostic services. It also owns or partners with physicians, physician practices, imaging centers, and ambulatory surgery centers. In addition, the company provides management and consulting services to non-affiliated general acute care hospitals. As of December 31, 2009, it owned or leased 122 hospitals with an aggregate of 18,140 licensed beds in non-urban and selected urban markets in 29 states. The company also owned and operated four home care agencies. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

INTERVEST BANCSHARES CORP-A (NASDAQ:IBCA) - Intervest Bancshares Corporation operates as the holding company for Intervest National Bank and Intervest Mortgage Corporation, which engage in banking and real estate lending businesses. The company offers various deposit products, including certificates of deposit, individual retirement accounts, checking and other demand deposit accounts, negotiable order of withdrawal accounts, savings accounts, and money market accounts. Its loan portfolio comprises mortgage loans secured by commercial and multifamily real estate properties, including rental and cooperative/condominium apartment buildings, office buildings, mixed-use properties, shopping centers, hotels, restaurants, industrial/warehouse properties, parking lots/garages, mobile home parks, self storage facilities, and vacant lands; commercial real estate loans; residential multifamily loans; land development and other land loans; residential 1-4 family loans; commercial business loans; and consumer loans. In addition, it offers Internet banking services; automated teller machine services with access to local, state, and national networks; wire transfers; automated clearing house transfers; direct deposit of payroll and social security checks; automated drafts for various accounts; and safe deposit boxes. The company has one full-service banking office in New York City; and six full-service banking offices in Pinellas County, Florida, of which four are in Clearwater, one in Clearwater Beach, and one in South Pasadena. The company was founded in 1993 and is headquartered in New York, New York.

NANOVIRICIDES INC (OTCBB:NNVC) - NanoViricides, Inc., a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States. It has licenses in perpetuity to develop drugs for the treatment of human viral diseases, such as human immunodeficiency virus, Hepatitis B Virus, Hepatitis C Virus (HCV), Herpes Simplex Virus, Rabies, Influenza, and Asian Bird Flu Virus. The companys products under development include FluCide-I for the treatment of common influenzas and avian influenza H5N1; AviFluCide-I against H5N1, the avian influenza strain; FluCide-HP against highly pathogenic avian influenza viruses; RabiCide-I, a nanoviricide against rabies; and HCV, a Hepatitis C nanoviricide. It also provides HivCide-I, a drug project against HIV-I; HivCide-II, a targeted nanoviricide against HIV strains; and EKCCide-I, a nanoviricide drug, which indicates efficacy and safety of a drug candidate against the severe pink eye disease caused by adenoviruses called epidemic kerato-conjunctivitis. NanoViricides, Inc. has a pre-clinical study agreement with Thevac, LLC for the evaluation of the companys universal anti-influenza drug candidate FluCide; and has a research agreement with the University of California-San Francisco for testing of its anti-HIV drug candidates. The company was founded in 2005 and is headquartered in West Haven, Connecticut.

SEARCHMEDIA HOLDINGS LTD (AMEX:IDI) - SearchMedia Holdings Ltd operates as a blank check company and is based in Beverly Hills, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net